BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Yu X, Wang S, Dai E, Jiang L, Wang J, Yang Q, Yang F, Zhou S, Jiang W. The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer. Oncotarget. 2016;7:57228-57238. [PMID: 27528026 DOI: 10.18632/oncotarget.11128] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang F, Liang S, Liu X, Han L, Wang J, Du Q. LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer. Onco Targets Ther 2018;11:6383-94. [PMID: 30323616 DOI: 10.2147/OTT.S169307] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wang Q, Yang Q, Chen G, Du Z, Ren M, Wang A, Zhao H, Li Z, Zhang G, Song Y. LncRNA expression profiling of BMSCs in osteonecrosis of the femoral head associated with increased adipogenic and decreased osteogenic differentiation. Sci Rep 2018;8:9127. [PMID: 29904151 DOI: 10.1038/s41598-018-27501-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
3 Zhou S, Wang L, Yang Q, Liu H, Meng Q, Jiang L, Wang S, Jiang W. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes. Breast Cancer Res Treat 2018;169:267-75. [PMID: 29388017 DOI: 10.1007/s10549-018-4678-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
4 Zhong H, Yang J, Zhang B, Wang X, Pei L, Zhang L, Lin Z, Wang Y, Wang C. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2. Cancer Biomark 2018;22:787-97. [PMID: 29945347 DOI: 10.3233/CBM-181354] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
5 Luan T, Zhang X, Wang S, Song Y, Zhou S, Lin J, An W, Yuan W, Yang Y, Cai H. Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p. Oncotarget. 2017;8:76153-76164. [PMID: 29100300 DOI: 10.18632/oncotarget.19190] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 14.0] [Reference Citation Analysis]
6 Flippot R, Beinse G, Boilève A, Vibert J, Malouf GG. Long non-coding RNAs in genitourinary malignancies: a whole new world. Nat Rev Urol 2019;16:484-504. [PMID: 31110275 DOI: 10.1038/s41585-019-0195-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
7 Shi X, Zhao Y, He R, Zhou M, Pan S, Yu S, Xie Y, Li X, Wang M, Guo X, Qin R. Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma. Oncotarget. 2018;9:24248-24259. [PMID: 29849937 DOI: 10.18632/oncotarget.24443] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
8 Li FZ, Zang WQ. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. World J Gastroenterol 2019; 25(42): 6299-6310 [PMID: 31754291 DOI: 10.3748/wjg.v25.i42.6299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Sun M, Chen Y, Liu X, Cui Y. LncRNACASC9 promotes proliferation, metastasis, and cell cycle inovarian carcinoma cells through cyclinG1/TP53/MMP7 signaling. Bioengineered 2021;12:8006-19. [PMID: 34595994 DOI: 10.1080/21655979.2021.1981795] [Reference Citation Analysis]
10 Liu KS, Li TP, Ton H, Mao XD, Chen YJ. Advances of Long Noncoding RNAs-mediated Regulation in Reproduction. Chin Med J (Engl) 2018;131:226-34. [PMID: 29336373 DOI: 10.4103/0366-6999.222337] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
11 Yamaguchi M, Lee IS, Jantrapirom S, Suda K, Yoshida H. Drosophila models to study causative genes for human rare intractable neurological diseases. Exp Cell Res 2021;403:112584. [PMID: 33812867 DOI: 10.1016/j.yexcr.2021.112584] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Trotta MC, Gesualdo C, Platania CBM, De Robertis D, Giordano M, Simonelli F, D'Amico M, Drago F, Bucolo C, Rossi S. Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? Biochem Pharmacol 2021;186:114473. [PMID: 33607073 DOI: 10.1016/j.bcp.2021.114473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li Y, Gu J, Lu H. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway. Dig Dis Sci. 2017;62:3426-3437. [PMID: 29098549 DOI: 10.1007/s10620-017-4831-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
14 Wei Y, Yan Z, Wu C, Zhang Q, Zhu Y, Li K, Xu Y. Integrated analysis of dosage effect lncRNAs in lung adenocarcinoma based on comprehensive network. Oncotarget 2017;8:71430-46. [PMID: 29069717 DOI: 10.18632/oncotarget.19864] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
15 Li L, Zhao W, Tao S, Leng R, Fan Y, Pan H, Ye D. Competitive endogenous RNA network: potential implication for systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2017;21:639-48. [DOI: 10.1080/14728222.2017.1319938] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
16 Sun N, Chen H, Ma Y, Pang W, Wang X, Zhang Q, Gao L, Li W. H3K4me3-Mediated Upregulation of LncRNA-HEIPP in Preeclampsia Placenta Affects Invasion of Trophoblast Cells. Front Genet 2020;11:559478. [PMID: 33424915 DOI: 10.3389/fgene.2020.559478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Qin N, Tong GF, Sun LW, Xu XL. Long Noncoding RNA MEG3 Suppresses Glioma Cell Proliferation, Migration, and Invasion by Acting as a Competing Endogenous RNA of miR-19a. Oncol Res 2017;25:1471-8. [PMID: 28276316 DOI: 10.3727/096504017X14886689179993] [Cited by in Crossref: 71] [Cited by in F6Publishing: 39] [Article Influence: 14.2] [Reference Citation Analysis]
18 Xu Z, Jin H, Duan X, Liu H, Zhao X, Fan S, Wang Y, Yao T. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis. Environ Toxicol 2021;36:2562-77. [PMID: 34520102 DOI: 10.1002/tox.23370] [Reference Citation Analysis]
19 Xing Q, Huang Y, Wu Y, Ma L, Cai B. Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma. PeerJ 2018;6:e5124. [PMID: 30038853 DOI: 10.7717/peerj.5124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
20 Wang Y, Guo Z, Zhao Y, Jin Y, An L, Wu B, Liu Z, Chen X, Chen X, Zhou H, Wang H, Zhang W. Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients. Sci Rep 2017;7:8320. [PMID: 28814798 DOI: 10.1038/s41598-017-08890-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
21 Yang H, Shang D, Xu Y, Zhang C, Feng L, Sun Z, Shi X, Zhang Y, Han J, Su F, Li C, Li X. The LncRNA Connectivity Map: Using LncRNA Signatures to Connect Small Molecules, LncRNAs, and Diseases. Sci Rep 2017;7:6655. [PMID: 28751672 DOI: 10.1038/s41598-017-06897-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
22 Liu G, Zheng J, Zhuang L, Lv Y, Zhu G, Pi L, Wang J, Chen C, Li Z, Liu J, Chen L, Cai G, Zhang X. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma. Sci Rep 2018;8:15250. [PMID: 30323196 DOI: 10.1038/s41598-018-33642-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
23 Li J, Shen H, Xie H, Ying Y, Jin K, Yan H, Wang S, Xu M, Wang X, Xu X, Xie L. Dysregulation of ncRNAs located at the DLK1‑DIO3 imprinted domain: involvement in urological cancers. Cancer Manag Res 2019;11:777-87. [PMID: 30697070 DOI: 10.2147/CMAR.S190764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
24 Guo Z, Han L, Fu Y, Wu Z, Ma Y, Li Y, Wang H, Jiang L, Liang S, Wang Z, Li F, Xiao W, Wang J, Wang Y. Systematic Evaluation of the Diagnostic and Prognostic Significance of Competitive Endogenous RNA Networks in Prostate Cancer. Front Genet 2020;11:785. [PMID: 32849794 DOI: 10.3389/fgene.2020.00785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Song X, Rui C, Meng L, Zhang R, Shen R, Ding H, Li J, Li J, Long W. Long non-coding RNA RPAIN regulates the invasion and apoptosis of trophoblast cell lines via complement protein C1q. Oncotarget 2017;8:7637-46. [PMID: 28032589 DOI: 10.18632/oncotarget.13826] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
26 Tao H, Zhang JG, Qin RH, Dai C, Shi P, Yang JJ, Deng ZY, Shi KH. LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. Toxicology 2017;386:11-8. [PMID: 28526319 DOI: 10.1016/j.tox.2017.05.007] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 17.0] [Reference Citation Analysis]
27 Kong Q, Qiu M. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p. Biochem Biophys Res Commun. 2018;495:1594-1600. [PMID: 29217194 DOI: 10.1016/j.bbrc.2017.12.013] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 15.2] [Reference Citation Analysis]
28 Liu D, Song L, Liang Q, Hao L, Zhang Z, Han C. Long noncoding RNA LEF1‐AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR‐330‐5p via LEF1 repression. J Cell Physiol 2019;234:12727-44. [DOI: 10.1002/jcp.27893] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
29 Hu X, Li Y, Kong D, Hu L, Liu D, Wu J. Long noncoding RNA CASC9 promotes LIN7A expression via miR-758-3p to facilitate the malignancy of ovarian cancer. J Cell Physiol 2019;234:10800-8. [PMID: 30537154 DOI: 10.1002/jcp.27903] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
30 Wei Y, Chang Z, Wu C, Zhu Y, Li K, Xu Y. Identification of potential cancer-related pseudogenes in lung adenocarcinoma based on ceRNA hypothesis. Oncotarget 2017;8:59036-47. [PMID: 28938616 DOI: 10.18632/oncotarget.19933] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen Y, Gu M, Liu C, Wan X, Shi Q, Chen Q, Wang Z. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2. Gene 2019;686:37-42. [PMID: 30389560 DOI: 10.1016/j.gene.2018.10.085] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]